These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2357862)

  • 21. Three controlled trials of weight loss with phenylpropanolamine.
    Altschuler S; Conte A; Sebok M; Marlin RL; Winick C
    Int J Obes; 1982; 6(6):549-56. PubMed ID: 6761288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release.
    Mannelli M; Delitala G; De Feo ML; Maggi M; Cuomo S; Piazzini M; Guazzelli R; Serio M
    J Clin Endocrinol Metab; 1984 Jul; 59(1):74-8. PubMed ID: 6725527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenylpropanolamine potentiates caffeine neurotoxicity in rats.
    Walker JS
    J Pharm Sci; 1989 Dec; 78(12):986-9. PubMed ID: 2614700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.
    Csajka C; Haller CA; Benowitz NL; Verotta D
    Br J Clin Pharmacol; 2005 Mar; 59(3):335-45. PubMed ID: 15752380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of caffeine on plasma renin activity, catecholamines and blood pressure.
    Robertson D; Frölich JC; Carr RK; Watson JT; Hollifield JW; Shand DG; Oates JA
    N Engl J Med; 1978 Jan; 298(4):181-6. PubMed ID: 339084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between stimulants: effects on DRL performance and lethality in rats.
    Michaelis RC; Holloway FA; Bird DC; Huerta PL
    Pharmacol Biochem Behav; 1987 Jun; 27(2):299-306. PubMed ID: 3628444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of multiple doses of phenylpropanolamine on the blood pressure of patients whose hypertension was controlled with beta blockers.
    O'Connell MB; Gross CR
    Pharmacotherapy; 1991; 11(5):376-81. PubMed ID: 1684039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Effects of Caffeine on Heart Rate Variability, Blood Pressure and Tidal Volume in Paraplegic and Tetraplegic Compared to Able-Bodied Individuals: A Randomized, Blinded Trial.
    Flueck JL; Schaufelberger F; Lienert M; Schäfer Olstad D; Wilhelm M; Perret C
    PLoS One; 2016; 11(10):e0165034. PubMed ID: 27776149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of caffeine on the metabolic and catecholamine responses to exercise in 5 and 28 degrees C.
    Anderson DE; Hickey MS
    Med Sci Sports Exerc; 1994 Apr; 26(4):453-8. PubMed ID: 8201901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of epinephrine in the circulatory effects of coffee.
    Smits P; Pieters G; Thien T
    Clin Pharmacol Ther; 1986 Oct; 40(4):431-7. PubMed ID: 3530587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time dependent pharmacokinetic interaction between phenylpropanolamine and chlorpheniramine maleate in human subjects.
    Rao VV; Rambhau D; Rao BR; Srinivasu P
    Drug Metabol Drug Interact; 1999; 15(4):259-68. PubMed ID: 10716040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity of over-the-counter stimulants.
    Pentel P
    JAMA; 1984 Oct; 252(14):1898-903. PubMed ID: 6471321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically significant pharmacokinetic interactions between dietary caffeine and medications.
    Carrillo JA; Benitez J
    Clin Pharmacokinet; 2000 Aug; 39(2):127-53. PubMed ID: 10976659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenylpropanolamine and caffeine use among diet center clients.
    Lake CR; Rosenberg D; Quirk R
    Int J Obes; 1990 Jul; 14(7):575-82. PubMed ID: 2228392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of phenylpropanolamine hydrochloride on blood pressure in Korean patients with hypertension controlled by hydrochlorothiazide.
    Sands CD; Jung KM; Jones DW; Kim HJ
    Clin Pharm; 1992 Feb; 11(2):168-73. PubMed ID: 1551298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the cardiovascular effects of phenylpropanolamine and phenylephrine containing proprietary cold remedies.
    Thomas SH; Clark KL; Allen R; Smith SE
    Br J Clin Pharmacol; 1991 Dec; 32(6):705-11. PubMed ID: 1722692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potent pressor effect of phenylpropanolamine in patients with autonomic impairment.
    Biaggioni I; Onrot J; Stewart CK; Robertson D
    JAMA; 1987 Jul; 258(2):236-9. PubMed ID: 3599310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cough and cold remedies: a potential danger to patients on monoamine oxidase inhibitors.
    Cuthbert MF; Greenberg MP; Morley SW
    Br Med J; 1969 Feb; 1(5641):404-6. PubMed ID: 5763957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coinciding exercise with peak serum caffeine does not improve cycling performance.
    Skinner TL; Jenkins DG; Taaffe DR; Leveritt MD; Coombes JS
    J Sci Med Sport; 2013 Jan; 16(1):54-9. PubMed ID: 22658588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of caffeine on metabolic responses of men at rest in 28 and 5 degrees C.
    MacNaughton KW; Sathasivam P; Vallerand AL; Graham TE
    J Appl Physiol (1985); 1990 May; 68(5):1889-95. PubMed ID: 2361891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.